1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (6429)
  2. Meeting Abstract (3246)
  3. Editorial (116)
  4. Review (93)
  5. Research Letter (80)
  6. Correspondence (77)
  7. Conference Paper (54)
  8. Miscellaneous (52)
  9. Book Section (43)
  10. Guidelines (13)
  11. Book Whole (5)
Groups
  1. Epidemiology and Biostatistics (10208)
  2. Biostatistics Service (6565)
  3. Department of Medicine (4908)
  4. Population Sciences Research Program (4867)
  5. Surgery (3680)
  6. Survivorship Research (3598)

More Groups

People
  1. Mithat Gonen (1028)
  2. Andrew Vickers (880)
  3. Sean Devlin (601)
  4. Katherine Panageas (512)
  5. Sujata Patil (511)
  6. Nikolaus Schultz (486)

More People

Years
  1. 2025 (210)
  2. 2024 (622)
  3. 2023 (692)
  4. 2022 (732)
  5. 2021 (610)
  6. 2020 (625)

More Years

Publications
  1. Journal of Clinical Oncology (1374)
  2. Blood (534)
  3. Annals of Surgical Oncology (462)
  4. Cancer Research (274)
  5. International Journal of Radiation Oncology, Biology, Physics (258)
  6. Clinical Cancer Research (250)

More Publications

Publishers
  1. American Society of Clinical Oncology (1487)
  2. Elsevier Inc. (1206)
  3. Springer (925)
  4. American Association for Cancer Research (761)
  5. Elsevier Science, Inc. (685)
  6. American Society of Hematology (601)

More Publishers

Results (10208)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer
    Meeting Abstract

    Gajria, D.; King, T. A.; Pannu, H.; Sakr, R.; Seidman, A. D.; Syldor, A.; Patil, S.; Maybody, M.; Norton, L.; Rosen, N.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis
    Meeting Abstract

    Elkin, E. B.; Lowrance, W. T.; Denton, B.; Mirkin, J. N.; Eastham, J. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A pilot study of vaccination with sialyl Lewis(a) (sLe(a))-keyhole limpet hemocyanin (KLH) conjugate plus the immunologic adjuvant QS-21 in metastatic breast cancer patients (pts)
    Meeting Abstract

    Diab, A.; Ragupathi, G.; Scholz, W. W.; Panageas, K.; Hudis, C.; Livingston, P. O.; Gilewski, T.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Time to tumor progession (TTP) of patients with octreotide-positive metastatic low-grade well-differentiated gastrointestinal neuroendocrine tumors (GEPNETs)
    Meeting Abstract

    Do, K. G.; Wyluda, E.; Capanu, M.; Tang, L. H.; Reidy, D. L.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Acupuncture for chemotherapy-induced fatigue: A randomized controlled trial
    Meeting Abstract

    Deng, G. E.; Chan, Y.; Yeung, K. S.; Vickers, A. J.; Cassileth, B. R.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Long-term cardiac safety and outcomes of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
    Meeting Abstract

    Dang, C. T.; Morris, P. G.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R.; Steingart, R.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase II trial of sorafenib (S) and dacarbazine (D) in leiomyosarcoma (LMS), synovial sarcoma (SS), and malignant peripheral nerve sheath tumor (MPNST)
    Meeting Abstract

    D'Adamo, D. R.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C.; Qin, L.; Antonescu, C.; Lefkowitz, R. A.; Schwartz, G. K.; Maki, R. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis
    Meeting Abstract

    Callahan, M. K.; Yang, A.; Tandon, S.; Xu, Y.; Subudhi, S. K.; Roman, R. A.; Heine, A. I.; Pogoriler, E.; Kuk, D.; Panageas, K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC)
    Meeting Abstract

    Balar, A. V.; Milowsky, M. I.; Apolo, A. B.; Ostrovnaya, I.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Bajorin, D. F.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical/pathologic features and survival of patients with fibrolamellar-hepatocellular carcinoma (FLL-HCC): Data from the Fibrolamellar-Hepatocellular (FLL-HCC) Consortium
    Meeting Abstract

    Ang, C.; Venook, A. P.; Choti, M. A.; DeMatteo, R. P.; Kelley, R. K.; Cosgrove, D.; McGuire, J. P.; Torbenson, M. S.; Pawlik, T. M.; Jarnagin, W. R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save